CD8A and neoplasm: It has been reported that immune-related therapeutic effects of locally ablative RT require intact immunity, type I interferon production and infiltration of CD8+ T cells (67), highlighting the importance of functional anti-tumor immunity in the current era of radio-immunotherapy.